PHIA Koninklijke Philips N.V.

Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26

Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26

March 10, 2026

Amsterdam, the Netherlands, and Las Vegas, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous, actionable understanding of the patient.

Health systems are under unprecedented pressure, with rapidly growing data volumes stretching clinical capacity and contributing to care delays. Delays are often compounded by fragmented data across monitoring systems, imaging platforms, and clinical applications. Philips’ found that 77% of healthcare professionals have lost clinical time due to issues with incomplete or inaccessible patient data [1]. As providers look for ways to expand capacity without adding burden, AI is increasingly being adopted to help automate routine tasks and surface relevant insights sooner. Yet scaling AI requires trusted, interoperable, longitudinal data that can be contextualized in clinical workflows.

Philips’ platforms are designed to connect data, devices, and teams across care settings and diagnostic domains. By linking medical devices, patient monitoring systems, imaging platforms, and health information systems – including EMR and third-party technologies – Philips enables health systems to create a unified data foundation that supports continuous visibility and longitudinal insight across the enterprise. At HIMSS26, Philips is showcasing two core capabilities that help make this connected care intelligence possible: enterprise patient monitoring that enables longitudinal care intelligence, and Integrated Diagnostics that brings imaging and diagnostic data together across the enterprise.

“Care is longitudinal – it doesn’t begin or end at the hospital door,” said Julia Strandberg, Chief Business Leader Connected Care at Royal Philips. “When data is connected across environments, clinicians can see a more continuous patient trajectory rather than disconnected snapshots. That broader context helps reduce noise, improve situational awareness, and allow care teams to focus their time on what matters most: earlier intervention and better patient outcomes.”

Enterprise patient monitoring – enabling longitudinal care intelligence

Across the acute and post-acute continuum, clinicians need continuous visibility that travels with the patient. Philips is advancing longitudinal care intelligence by connecting enterprise monitoring with interoperable clinical data – so physiologic signals remain visible as patients move across care settings, including in high-acuity environments, during transitions of care, and after discharge.

By integrating medical devices and health information systems, including EMRs and a broad ecosystem of third-party devices, Philips helps create a connected data thread with that support clinical decision-making across encounters and over time. This longitudinal foundation can help reduce workflow friction for care teams. Connected monitoring can also support strategies to relieve pressure on high-acuity environments by supporting safe, early discharge with oversight beyond the hospital walls.

Integrated Diagnostics – enterprise imaging integration to help reduce workload

A complete patient story also depends on diagnostics. Yet in many hospitals, diagnostic imaging data live in disconnected systems across radiology, cardiology, pathology, and other specialties. Clinicians often navigate multiple viewers, logins, and workflows to access the information needed to make decisions.

Integrated Diagnostics connects diagnostic systems, workflows, and AI applications so clinicians can access a more unified view of patient imaging and diagnostic data when decisions cannot wait. Philips’ portfolio provides a comprehensive suite of cloud-based solutions designed to connect data, integrate workflows, and embed AI across the diagnostic enterprise.

“Integrated Diagnostics isn’t about adding another tool – it’s about connecting the diagnostic enterprise, so clinicians aren’t forced to assemble the story themselves,” said Shez Partovi, Chief Innovation Officer and Chief Business Leader of Enterprise Informatics at Royal Philips. “When cardiology, radiology, pathology and other diagnostic domains come together on a connected foundation, teams gain a more unified view of the patient, time to diagnosis can drop, and intelligence can be embedded into everyday workflows in a way that truly scales.”

Philips’ platform approach is built with cybersecurity, privacy, and responsible AI practices at its core. Trust is foundational to enabling data liquidity across the enterprise, supporting longitudinal context, and scaling AI in ways that strengthen clinical decision-making while minimizing unnecessary complexity.

Experience Philips at HIMSS26

At HIMSS26, Philips is demonstrating how enterprise patient monitoring and Integrated Diagnostics can reduce fragmentation, accelerate insight, and support confident action across care environments and diagnostic workflows – while giving clinicians time back to deliver better care. For more information about solutions highlighted at HIMSS26, visit .

[1] Philips Future Health Index 2025. Available at:

For further information, please contact:

Anna Hogrebe

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
10/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch